AI tailors radiation in Real-Time for brain tumor patients
NCT ID NCT06492486
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study tests a new way to deliver radiation for brain tumors called adaptive radiotherapy, guided by artificial intelligence. About 60 adults with diffuse glioma will get MRI and PET scans during treatment so the radiation dose can be adjusted to target resistant areas and protect healthy tissue. The goal is to improve tumor control and reduce side effects, while building an AI system to make treatment planning faster and more precise.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.